Our Bimal Desai, PhD, has discovered an electrical switch within a certain type of immune cell that could let us treat inflammatory diseases including inflammation of the brain, as seen in Parkinson’s disease and Alzheimer’s, for the first time.
What he found was that this switch, called an ion channel, controls the flow of calcium into immune cells called macrophages. Block the calcium entering through this ion channel and you can stop the inflammation. This could be useful not just against inflammation such as seen in arthritis and inflammatory bowel disease but also chronic inflammation seen in cardiovascular diseases and in the brain, where most biological drugs can’t reach.
His team was able to make this discovery because of something rather rare in immunology labs: the additional ability to do both electrophysiology – the study of the flow of electrical currents in cells and tissues – and calcium imaging in living cells.
“Both techniques are fairly sophisticated and require a great deal of experience to do right,” said Dr. Desai, of the Department of Pharmacology. “You are dealing with complex equipment, you have to have a good understanding of imaging, optics and biophysics. The training required is in order of years and it requires a significant amount of time to get good at it. The physical setup is not easily established, so if an immunologist comes across an ion channel in their area of disease they’re interested in, they can’t just say, ‘OK, we’ll start doing that in the lab.’ That depth of technical talent is a big help when it comes to research like this.”
Because Dr. Desai’s lab can do both electrophysiology and calcium imaging in immune cells, he gets requests from immunologists all over – so many he can’t keep up. “These are skill sets that are now heavily courted throughout the nation” he said.
He noted that there is a shortage of expertise in electrophysiology in general. UVA is fortunate to have several expert electrophysiologists, such as Douglas Bayliss and Julius Zhu, two outstanding neuroscientists in the Department of Pharmacology.
We’re lucky to have such technical abilities, and we’re also lucky to have great expertise in the white-hot field of neuroimmunology, which studies the interaction of the nervous system and the immune system. You may recall that our Dr. Jonathan Kipnis, PhD, made the astounding discovery that the brain is connected to the immune system by vessels long thought not to exist.
“UVA is very strong in neuroimmunology, with Dr. Kipnis and BIG [our Center for Brain Immunology and Glia],” Desai said. “So I think we sit at a great juncture in history where we have the right technical expertise to move forward but also an environment here to do ground-breaking neuroimmunology that is tremendously strong.”
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- Biohaven Receives FDA May Proceed Letter to Begin Phase 2 Trial of Intranasal Vazegepant to Treat Lung Inflammation After COVID-19 Infectionon April 9, 2020 at 4:30 am
IL-6 is an important mediator of inflammation that is elevated in the sickest of COVID-19 patients. In addition, CGRP may be involved in the polarization of the T cell response in some COVID-19 ...
- First in-human study of drug targeting brain inflammation supports further developmenton April 9, 2020 at 12:16 am
Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury ...
- Linking lipids and disease: Making the connection between fatty acids, inflammation, and tissue homeostasison April 8, 2020 at 11:48 pm
Liquid chromatography tandem mass spectrometry (LC-MS/MS) is a powerful method for analyzing lipid metabolites, providing insight into the structure and function of endogenous lipid metabolites that ...
- Pneumonia, uncontrolled inflammation more common in COVID-19 with diabeteson April 8, 2020 at 8:41 am
Researchers found that patients with COVID-19 and diabetes, but no other comorbidities (n = 24), were at higher risk for severe pneumonia, release of tissue injury-related enzymes, excessive ...
- Cancer-causing mutation also promotes inflammationon April 8, 2020 at 7:44 am
Patients affected by JMML carrying these mutations suffer particularly often from signs of inflammation, such as fever, weight loss, and an abnormal enlargement of the spleen. It was previously ...
- Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammationon April 8, 2020 at 2:20 am
These results show that S166 autophosphorylation licenses RIPK1 kinase activity to induce downstream cell death signaling and inflammation, suggesting that S166 phosphorylation can serve as a reliable ...
- Worry, Anxiety Tied to Increased Inflammationon April 7, 2020 at 10:00 am
"Further, stress significantly impacts the immune system, but very few studies have looked at how worry specifically influences inflammation," Renna said. The findings were scheduled to be presented ...
- Human skin suppresses inflammation after exposure to ultraviolet radiationon April 7, 2020 at 5:46 am
A study led by an NIHR Manchester Biomedical Research Centre scientist has identified, for the first time, how the human skin suppresses inflammation after exposure to ultraviolet radiation (UVR). Dr.
- Do that last squat – CBD can help reduce exercise-induced inflammationon April 6, 2020 at 5:56 pm
In your exercise routine, do that last squat if you want to achieve your goals. But you skip the final reps because you’re afraid you’ll later feel pain. Well, inflammation is part of muscle training ...
- Ocular Inflammation Treatment Market to Witness a Pronounce Growth during 2020 to 2025on April 2, 2020 at 3:32 am
New York, April 02, 2020: The report covers detailed competitive outlook including the market share and company profiles ...
via Bing News